Growth curve of M. smegmatis PLJR962-eccD3-gRNA strain with ivermectin.

Growth curve of M. smegmatis PLJR962-eccD3-gRNA strain with ivermectin.

<p>Growth curves of <i>M. smegmatis mc</i><sup><i>2</i></sup> 155 wild type strain (diamonds, inner graph (<b>a)</b> and (c), <i>M. smegmatis</i> PLJR962-<i>eccD3</i>-gRNA strain (circles) (<b>a)</b> and (b), a...

Full description

Saved in:

Bibliographic Details
Main Author:	Ana Laura Granados-Tristán (21144439) (author)
Other Authors:	Mauricio Carrillo-Tripp (3183507) (author), Carlos Eduardo Hernández-Luna (21144442) (author), Aldo Herrera-Rodulfo (21144445) (author), Laura Adiene González-Escalante (8890166) (author), Ana Leticia Arriaga-Guerrero (8890154) (author), Beatriz Silva-Ramírez (8890169) (author), Brenda Leticia Escobedo-Guajardo (18809428) (author), Roberto Mercado-Hernández (8890172) (author), Mario Bermúdez de León (21144448) (author), Katia Peñuelas-Urquides (11639896) (author)
Published:	2025
Subjects:	Biophysics Biochemistry Medicine Microbiology Molecular Biology Pharmacology Biotechnology Cancer Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified inhibited using crispri 3 secretion system favorable δg values tertiary protein structures new therapeutic targets eccd3 dimer interfaces div >< p mycolicibacterium smegmatis </ mycobacterium tuberculosis </ ivermectin susceptibility increased mycobacterium susceptibility smegmatis </ tuberculosis </ new drugs molecular structures ivermectin targets eccd3 protein eccd3 increased best δg resistant tuberculosis vitro </ silico </ eccd3 </ zinc homeostasis quaternary interface prospective drugs predicted based preclinical studies ivermectin action compensatory mechanisms
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_5cmsechjadec46hjfqe8j09dps